Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2014 by Bayside Health.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Monash Medical Centre
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Bayside Health
ClinicalTrials.gov Identifier:
NCT00662194
First received: April 17, 2008
Last updated: March 6, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2014
  Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)